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The dysbiotic microbiota associated with aggressive periodontitis includes
Aggregatibacter actinomycetemcomitans, the only oral species known to produce a
cytolethal distending toxin (AaCDT). Give that CDT alters the cytokine profile in monocytic
cells, we aimed to test the hypothesis that CDT plays a role in bone homeostasis by
affecting the differentiation of precursor cells into osteoclasts. Recombinant AaCDT
was added to murine bone marrow monocytes (BMMC) in the presence or absence
of RANKL and the cell viability and cytokine profile of osteoclast precursor cells were
determined. Multinucleated TRAP+ cell numbers, and relative transcription of genes
related to osteoclastogenesis were also evaluated. The addition of AaCDT did not
lead to loss in cell viability but promoted an increase in the average number of TRAP+
cells with 1-2 nuclei in the absence or presence of RANKL (Tukey, p < 0.05). This
increase was also observed for TRAP+ cells with ≥3nuclei, although this difference
was not significant. Levels of TGF-β, TNF-α, and IL-6, in the supernatant fraction of
cells, were higher when in AaCDT exposed cells, whereas levels of IL-1β and IL-10
were lower than controls under the same conditions. After interaction with AaCDT,
transcription of the rank (encoding the receptor RANK), nfatc1 (transcription factor),
and ctpK (encoding cathepsin K) genes was downregulated in pre-osteoclastic cells.
The data indicated that despite the presence of RANKL and M-CSF, AaCDT may inhibit
osteoclast differentiation by altering cytokine profiles and repressing transcription of
genes involved in osteoclastogenesis. Therefore, the CDT may impair host defense
mechanisms in periodontitis.
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INTRODUCTION
Aggregatibacter actinomycetemcomitans is considered to be the most prevalent member of the
HACEK group formed by Gram-negative facultative anaerobic bacteria related to endocarditis
(Paturel et al., 2004). This bacterium is also associated with aggressive periodontitis. The disease
is characterized by rapid and severe bone resorption for the age of onset that may be mediated by
bacteria and their products or by the activation of T cells that lead to an over-production of RANKL
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(receptor activator of nuclear factor-κβ ligand) and stimulation
of local osteoclastogenesis (Teng et al., 2000; Kawai et al., 2006).
The production of cytolethal distending toxin (CDT), along
with leukotoxin, is considered to be a primary virulence trait
of strains of A. actinomycetemcomitans that are associated with
the ability of the bacterium to evade host immune defenses
(Henderson et al., 2010). The A. actinomycetemcomitans CDT
is an AB2-type toxin (Shenker et al., 1999) that binds to lipid
rafts in the plasma membrane of eukaryotic cells via the CDTC
subunit (Boesze-Battaglia et al., 2009). The CDTB subunit is
the active part of the A. actinomycetemcomitans toxin exhibiting
DNA cleavage properties similar to those of DNase I (Lara-Tejero
and Galán, 2000). AaCDT arrests eukaryotic cells at the G0/G1 or
G2/M interphase of the cell cycle in most susceptible cell types.
Studies of various types of cells indicate a range of sensitivities
to the toxin. As in the case of other genotoxins, CDT-treated
cells can under some conditions activate DNA damage repair
responses and survive CDT intoxication (Frisan, 2016).
The AaCDT appears to be especially toxic for lymphocytes
and epithelial cells (Ohguchi et al., 1998; Shenker et al., 2001;
Belibasakis et al., 2004; Mise et al., 2005; Smith and Bayles, 2006)
by activation of apoptosis mechanisms and blocking proliferation
(Shenker et al., 2007). However, the data on susceptibility to
CDTmediated apoptosis in non-proliferatingmonocytic cells are
controversial (Rabin et al., 2009).
CDT intoxication can also result in impaired functions of
the surviving target cell (Hickey et al., 2000; Ando-Suguimoto
et al., 2014). Previous data revealed that AaCDT can target
monocytic cells, such as macrophages, altering their phagocythic
capacity and cytokines profiles (Akifusa et al., 2001; Mise et al.,
2005; Fernandes et al., 2008; Ando-Suguimoto et al., 2014;
Belibasakis and Bostanci, 2014). Osteoclast precursors derive
from the monocyte /macrophage hematopoietic lineage and their
differentiation into osteoclasts is mediated by the ligation of
RANKL with its receptor RANK, which then activates different
signaling pathways (Cicek et al., 2011).
Despite, the evidences of AaCDT is related to increased
production of RANKL by fibroblasts (Belibasakis et al., 2005a,b),
andHaemophilus ducreyiCDT in Jurkat T-cells (Belibasakis et al.,
2008), the role of CDT in osteoclasts differentiation is still not
elucidated. Cytokines play an important role in inflammatory
bone destruction by upregulating the production of RANKL
(Moon et al., 2013). In vivo, osteoclastogenesis is supported by
T-cells, which produce not only RANKL, but cytokines, such
as TNF-α (Brunetti et al., 2005) and IL-7 (Colucci et al., 2005),
which are involved in the process. Moreover, osteoclast precursor
cells express cytokine receptors as IL-1, TNF-α, IFN-γ, IL-6,
and IL-17, which positively influence osteoclastogenesis (Boyle
et al., 2003; Bishop et al., 2009; Belibasakis and Bostanci, 2014).
On the other hand, osteoclastogenesis can be inhibited by IL-
10, osteoprotegerin (OPG), transforming growth factor beta
(TGF-β) and interferon regulatory factor 8 (IFR-8) (Boyle et al.,
2003; Evans and Fox, 2007; Takayanagi, 2007; Zhao et al., 2009;
Belibasakis and Bostanci, 2014).
Given the evidence, that the AaCDT may target monocytic
cells and CDT intoxication results in an altered cytokine profile,
we hypothesized that CDT plays a role in bone homeostasis by
affecting the differentiation of precursor cells into osteoclasts.
Thus, the aim of this study was to determine the effects of
AaCDT intoxication on osteoclast precursors such as murine
bone marrow cells (BMC).
MATERIALS AND METHODS
Recombinant Cytolethal Distending Toxin
from A. actinomycetemcomitans
His-tagged AaCDT subunits were purified from recombinant E.
coli pET15bcdtA, E. coli pET15bcdtB, and E. coli pET15bcdtC cell
lysates by affinity chromatography on NI-NDA columns (Life
Technologies, Carlsbad, CA). Active AaCDT was prepared by
combining CDTA-His6, CDTB-His6, and CDTC-His6 in a 1:1:1
molar ratio as described previously (Mao and DiRienzo, 2002;
Cao et al., 2006; Ando-Suguimoto et al., 2014). The trimeric toxin
was obtained after shaking the subunit suspension at 0◦C for
1 h. Non-reconstituted subunits were removed using an Amicon
centrifugal filter unit with a molecular weight cutoff of 50 kDa
(Millipore, Bilerica, MA). Protein concentration was estimated
using the Bradford assay (Bio-Rad Laboratories, Hercules, CA).
Animals
Six- to eight-weeks-old male C57BL/6 mice were purchased
from the Animal facility of isogenic mice, Immunology
Department of Biomedical Sciences Institute, University of
São Paulo (ICBUSP, São Paulo, SP, Brazil). Animals were
maintained under specific pathogen-free conditions at the
experimental facility, Department of Microbiology, ICBUSP,
kept in a conventional room with a 12-h light–dark cycle at
constant temperature, fed Nuvulab CR-1 (Quimtia, Colombo,
PR, Brazil) and allowed water ad libitum. All experimental
procedures were examined and approved by the Institutional
Animal Experimentation Ethics Committee (Approval ID
162/09/CEEA).
Bone Marrow Mononuclear Cells (BMMC)
Bone marrow cells were obtained from the femur and tibiae of
the C57BL/6 mice by flushing with Dulbecco’s modified Eagle’s
medium [DMEM (Gibco, Grand Island, NY) supplemented with
10% fetal calf serum (FCS), sodium bicarbonate (2.2 g/ml) using
an intradermal needle (BD precision glide). Cells were suspended
in the same medium supplemented with penicillin (1664U/ml)
and streptomycin (745U/ml).
BMMC were separated with Histopaque 1083 (Sigma—
Aldrich, Saint Louis, CA) and re-suspended in α-MEM
complete medium (Sigma—Aldrich) [supplemented with 15%
fetal calf serum (FCS), sodium bicarbonate (2.2 g/ml), penicillin
(100U/ml), streptomycin (100U/ml), and gentamicin (Sigma-
Aldrich), L-Glutamin (200mM) (Sigma-Aldrich), MEM non-
essential amino acids 1% (Gibco)]. α-MEM complete medium
was added with 20 ng/ml macrophage-colony-stimulating factor
(M-CSF, (Peprotech, Rocky Hill, NJ) which promotes survival
and proliferation of osteoclast precursors (Ross and Teitelbaum,
2005).
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Effect of AaCDT on BMMC
BMMC (2 × 105) were cultured in 96-well plates (Corning—
Costar) in α-MEM complete medium (Sigma—Aldrich)
supplemented with 20 ng/ml M-CSF and with or without
50 ng/ml RANKL (Peprotech, Rocky Hill, NJ) (Axmann et al.,
2009; Makihira et al., 2011). AaCDT was added to each well in
concentrations of 0, 12.5, and 25 µg/ml. The cells were incubated
at 37◦C with 5% CO2 in a fully humidified atmosphere for 6 days
and maintenance was done every 2 days by removing 50% of the
culture medium and adding the same volume of medium and its
supplements.
Negative control cells were cultured in medium containing
RANKL (50 ng/ml) and 100 ng/ml osteoprotegerin (OPG,
Peprotech, Rocky Hill, NJ), whereas positive control cells were
cultured in medium containing an optimal concentration of
RANKL (100 ng/ml). After 6 days of culture, cell viability,
the number of TRAP—positive multinuclear cells and gene
expression were determined.
Cell Viability Assay (MTT ASSAY)
Cell viability was determined by the addition of 10% MTT
solution (Sigma-Aldrich, 0.5mg/ml in PBS). After a 3-h
incubation period, the insoluble formazan crystals were dissolved
in 10% SDS and optical density (OD)measured at 540 nm using a
680 micro-plate reader (BioRad, Hercules, CA). Data are shown
as the mean± SD of three wells for each exposure group.
Trap-Positive Cell Counting
The number of TRAP+multinucleated cells was determined after
fixation, stained using the TRAP staining kit (387A, Sigma—
Aldrich) and examined by inverted light microscope (Nikon
Eclipse TS100) using a × 40 objective. TRAP+ cells presenting
1–2, 3–4,≥5 nuclei were counted in each well, and the mean and
standard deviation of the number of TRAP+ multinucleated cells
per well calculated for each condition, in triplicate assays.
Cytokine Production
The production of IL1-β, TNF-α, IL-10 IL-6, and TGF-β
was determined in cell supernatants using enzyme-linked
immunosorbent assay (ELISA) commercial kits (Peprotech,
Rocky Hill, NJ and R&D Systems, Minneapolis, MN—for
TGF-β). Absorbance values were read at 405 nm against a
standard curve and data expressed in ng/ml.
Relative Expression of Genes Associated
with Osteoclastogenesis
The cells were washed with PBS and total RNA was extracted
using Trizol reagent (Ambion/Life Technologies). RNA yield and
purity were determined using a spectrophotometer (Nanodrop
ND 1000, Peqlab, Erlangen, Germany). Purified RNA served as
template for the synthesis of cDNA using Superscript III First
Strand Synthesis System for RT-PCR (Invitrogen).
Transcription levels were determined by qPCR using cDNA
as a template in TaqMan inventoried assays for the rank (Mm
00437135_m1), ctpk (Mm 00484039_m1), nfatc-1 (Mm 00479445
_m1), irf-8 (Mm 00492567_m1), and gapdh (Mm 99999915_g1)
genes (Applied Biosystems). TaqMan Fast Universal PCR Master
Mix was added to the reactions (Applied Biosystems – Foster,
CA). PCR reactions were performed using an initial incubation
at 50◦C for 2min followed by 50 cycles of 95◦C for 10min, 95◦C
for 15min, and 60◦C for 1min, in a thermocycler (Step One Plus
Real-Time PCR system, Applied Biosystems).
The analysis of the relative quantification of genes related to
osteoclastogenesis was performed by using the 11Ct Method
(Pfaﬄ, 2001). Relative gene expression was determined after
normalization of data to transcription levels of the housekeeping
gene gapdh (glyceraldehyde-3-phosphate dehydrogenase) in each
sample.
Statistical Analysis
Differences in cell viability and production of cytokines among
groups were determined using ANOVA followed by Tukey.
Values were considered significant when p < 0.05. For gene
transcription profiles, Two-way ANOVA followed by Bonferroni
was used to assess differences between control and experimental
groups usingmeanCT-values derived from the triplicate samples.
Differences in gene expression were considered to be significant
when p < 0.05. For all analysis, Graphpad Prism version 4.0 was
used (La Jolla, CA).
RESULTS
Cell Viability Assay (MTT ASSAY)
Treatment of monocytes with the AaCDT (12.5 and 25.0 µg/ml)
for 6 days did not result in a loss of viability when RANKL
was omitted from or included in cultures (see Figures 1A,B,
respectively). Addition of 25.0 µg/ml of AaCDT resulted in a
slight but significant increase in BMMC viability when RANKL
was not added.
Trap-Positive Cell Counting
The addition of 12.5 and 25.0 µg/ml AaCDT led to an increase
in the number TRAP+ cells harboring one or two nuclei in
cultures lacking RANKL (Figure 2B), and in presence of RANKL
the AaCDT. The exposure to increasing concentrations of
AaCDT resulted in increased numbers of TRAP+ cells containing
3–4 nuclei, in a dose dependent way (Figure 2C), although
these differences were not statistically significant. TRAP+ cells
containing ≥3 nuclei as shown in Figure 2A, indicated that pre-
osteoclasts differentiated to osteoclasts. The exposure to AaCDT
in the presence of RANKL resulted also in increased numbers of
TRAP+ cells containing ≥5 nuclei (not significant).
Cytokine Production
After 6 days of incubation of monocyte with 12.5 or 25.0 µg/ml
of AaCDT in absence of RANKL (Figure 3A) and addition of
RANKL (Figure 3B), resulted in increased production of TGF-
β and decreased production of IL-1β in the cultures without
RANKL, but in the presence of RANKL, AaCDT exerted no effect
on cytokines levels.
Furthermore, exposure to AaCDT resulted in increased levels
of TNF-α and IL-6, and decreased levels of IL-10 in both assays,
with and without RANKL. Data are shown from one assay in
triplicate. The most dramatic changes promoted by AaCDT was
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FIGURE 1 | Effect of recombinant AaCDT on monocyte viability after 6 days of incubation. (A) without RANKL; (B) 50 ng/ml of RANKL. Cultures received
either 100 ng/ml RANKL; 100 ng/ml OPG, or 50 ng/ml of RANKL. Cultures containing the lower concentration of RANKL also received either 0, 12.5, or 25.0 µg/ml of
AaCDT. Statistically significant difference when compared to the culture lacking CDT (ANOVA-Tukey), **p < 0.01.
observed for IL-6, which levels doubled in cells receiving 12.5 and
25.0 µg/ml AaCDT with and without the addition of RANKL,
respectively. Furthermore, the levels of IL-10 were decreased by
50% in cells without RANKL exposed to 25.0 µg/ml of AaCDT,
and by 90% in cells with RANKL exposed to 12.5 and 25.0 µg/ml
of AaCDT.
Relative Expression of Genes Associated
with Osteoclastogenesis
BMMC were exposed to AaCDT at 12.5 or 25.0 µg/ml for 2,
4, and 6 days, in the presence or absence of RANKL, and gene
expression was determined. AaCDT did not significantly alter
expression of genes associated with osteoclastogenesis in the
absence of RANKL (Data not shown).
Relative transcription of genes associated with
osteoclastogenesis, including the transcription factor nfatc-1
and genes encoding the receptor RANK and the protease
cathepsin K, characteristic of osteoclasts, were increased in
BMMC treated with RANKL. Transcription levels of these genes
were more pronounced in the cells incubated with the optimal
concentration of RANKL (100 ng/ml) after 2 and 4 days, whereas
the addition of the suboptimal RANKL concentration (50 ng/ml)
resulted in a delay in the transcription of genes associated
with osteoclastogenesis. Transcription of the regulatory factor
ifr-8, which interrupts osteoclastogenesis, was induced in cells
submitted to 100 and 50 ng/ml RANKL after the transcription of
genes associated with osteoclastogenesis. The relative expression
of ifr-8 was also high for the RANKL treated- cells submitted to
OPG in all studied periods.
The transcription of all studied genes associated with
osteoclastogenesis in RANKL treated cells was always lower for
those cells exposed to CDT than to control cells treated only
with the same amount of RANKL (50 ng/ml) and even lower
than for those exposed to the RANKL and the osteoclastogenesis
inhibitor osteoprotegerin. Transcription analysis of cells treated
with RANKL and exposed to AaCDT for two days revealed a
downregulation of rank and cptK when compared with cells
not exposed to AaCDT, and this downregulation persisted till
the end of the experimental period (6 days). Furthermore, the
transcription of the regulatory gene ifr-8 was always low for the
AaCDT treated cells (Figure 4).
DISCUSSION
The cytolethal distending toxin has a wide distribution among
pathogenic Gram-negative bacteria (Guerra et al., 2011) and is
frequently associated with virulence (Fabris et al., 2002; Höglund
Åberg et al., 2013; Baig et al., 2015; Oloomi et al., 2015). The
cdt operon is located in regions of the A. actinomycetemcomitans
genome that contain elements suggestive of horizontal gene
transfer (Mayer et al., 1999; Kittichotirat et al., 2016) and its
maintenance in most strains of this species may be indicative of
an ecological advantage.
In the present study the influence of recombinant AaCDT
on osteoclast differentiation, as promoted by RANKL, was
determined and resulted in no loss of viability. This result
was consistent with the finding of other studies showing that
non-proliferating cells are relatively resistant to CDT-induced
apoptosis (Shenker et al., 2014).
The detection of TRAP+ cells with 1–2 nuclei and more than
three nuclei when monocyte cultures were exposed to AaCDT
(25.0 µg/ml), specially in the present of RANKL suggests that
AaCDT potentiates the osteoclastogenic effect of RANKL. In
vitro studies have indicated that the first TRAP+ multinucleated
cells containing three to four nuclei appear between the 2nd
and 4th day of culture with RANKL, while giant multinucleated
cells, producing markers of mature osteoclasts such as cathepsin
K, were only detected on day 5 (Makihira et al., 2011). Data
on osteoclast precursor cells revealed that only cells with more
Frontiers in Cellular and Infection Microbiology | www.frontiersin.org 4 March 2016 | Volume 6 | Article 33
Kawamoto et al. Alteration Homeostasis in Pre-osteoclasts by AaCDT
FIGURE 2 | Effect of AaCDT on the number of TRAP+ multinucleated cells. In (A) a representative photomicrograph illustrating TRAP stained BMMC cells after
6 days of incubation with 50 µg/ml RANKL, and different concentrations of AaCDT. Image magnification is 40x using Olympus BX60 microscope and NIS-Elements F
capture system (Nikon, Center Valley, PA, USA). Cells added with osteoprotegerin (OPG; 100 ng/ml) were used as negative controls or RANKL (100 ng/ml) used as
positive control. In (B) without, in (C) with the addition of 50 ng/ml of RANKL the average of TRAP+ cells per well. Controls (without AaCDT): (0) negative control;
(OPG) cells added with OPG 100ng/ml; (100 ng/ml RANKL) cells added with optimal RANKL concentration for osteoclastogenesis. Statistically significant difference
when compared with negative control (ANOVA-Tukey), *p < 0.05, **p < 0.01 and ***p < 0.001.
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FIGURE 3 | Cytokines levels (TGF-β, IL-1β, TNF-α, and IL-6) in cell supernatant of BMMC added with AaCDT (12.5 and 25.0 µg/ml) after 6 days of
incubation, in the absence (A) and presence (B) of 50ng/ml RANKL. Controls consisted of cells without AaCDT): (0) negative control; (OPG) cells added with
100 ng/ml osteoprotegerin; (100 ng/ml RANKL) cells added with optimal RANKL concentration for osteoclastogenesis. Statistically significant difference
(ANOVA-Tukey) when compared with negative control: *p < 0.05, **p < 0.01 and ***p < 0.001.
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FIGURE 4 | Relative expression genes associated with osteoclastogenesis (rank, nfatC1, ctpK, and ifr-8) in monocytes submitted to RANKL (50
ng/ml) and AaCDT (12.5 and 25.0 µg/ml), after 2, 4, and 6 days: Controls (without AaCDT): (0) negative control; (OPG) cells added with 100 ng/ml OPG;
(100ng/ml RANKL) cells added with optimal RANKL concentration for osteoclastogenesis. Statistically significant difference when compared with negative
control *p < 0.05; **p < 0.01 and ***p < 0.001 (Two way ANOVA—Bonferroni).
than 10 nuclei were able to reabsorb bone (Lees et al., 2001).
Thus, our data indicated that the effect of AaCDT on osteoclast
differentiation was more pronounced in the initiation of the
process, but AaCDT did not lead to significant increase in
TRAP+ cells with ≥5 nuclei, indicating that it may not lead to
differentiation into mature osteoclasts.
Osteoclast differentiation is a complex activity that is not only
dependent on an interaction with RANKL (Wythe et al., 2014)
but also that pro-inflammatory cytokines influences the process
(Takayanagi, 2010). The CDT-intoxicated osteoclast precursors
produced increased levels of TGF-β whereas levels of IL-1β
decreased indicating that these cells produced an altered cytokine
repertoire characteristic of osteoclastogenesis inhibition. TGF-β
is able to inhibit osteoclast formation and decrease the lifetime
of mature osteoclasts (Weitzmann et al., 2000) whereas IL-1β
synergizes with RANKL to promote later stages of osteoclast
differentiation (Lee et al., 2010).
On the other hand, AaCDT also led to increased levels of
TNF-α as previously shown for the monocytic cell lineage THP-1
(Ando-Suguimoto et al., 2014). TNF-α prolongs osteoclasts
survival (Lee et al., 2001) and induces the transcription
factor NFATc-1 (Kim et al., 2008) which, in turn, induces
osteoclastogenesis. Levels of IL-6 also increased after CDT
intoxication in pre-osteoclastic cells. The effect of IL-6 on
osteoclast precursor differentiation is dual since IL-6 can exhibit
both inhibitory and stimulatory effects (Yoshitake et al., 2008;
Axmann et al., 2009).
Our data indicated that IL-10 levels were decreased with high
doses of AaCDT after 6 days of incubation. These data may seem
contradictory since IL-10 is known to inhibit osteoclastogenesis
(Wei et al., 2005; Mohamed et al., 2007; Takayanagi, 2010;
Ivashkiv et al., 2011). However, it should be pointed out that
CDT induces IL-10 production in monocytic cells after 2 days
of intoxication (Akifusa et al., 2001), as expected, due to its
phosphatase activity, similar to SHIP (Hazeki et al., 2007, 2011).
Thus, a feedback effect may possibly result in the low IL-10
levels observed in CDT-intoxicated cells at the later stages of
incubation.
In order to demonstrate if mature osteoclasts were formed
from CDT-intoxicated pre-osteoclasts having an altered
cytokine profile, the transcription of genes associated with
osteoclastogenesis were also evaluated. The addition of
recombinant AaCDT to RANKL treated monocytes led to
down regulation of transcription of the rank and ctpk genes after
2 days of exposure (Figure 4), and this down regulation persisted
till the end of the experiment (day 6), indicating that AaCDT
repressed the transcription of these genes at the beginning of the
osteoclastogenesis process.
Osteoclastogenesis requires the connection of M-CSF with
its M-CSFR receptor, which activates proliferation and survival
of osteoclast precursors (Tanaka et al., 2006). Then, a cascade
in which RANK-RANKL (Receptor activation of NF-κB and its
ligand) signaling pathway leads to activation of NF-κB, followed
by the activation of molecular adaptor Grb-2-associated binder
two (GAB2), which induces the activation of the transcription
factor NFATc-1, mitogen-activated protein kinases (MAPKs),
C-SRC, and AKT (Boyle et al., 2003). These events promote
the osteoclast precursors to differentiate into mononuclear
osteoclasts. NFATc-1 then induces the formation of multinuclear
mature osteoclasts, characterized by the cathepsin K production
(Matsumoto et al., 2004), carbonic anhydrase II and H ±
ATPase (Asagiri and Takayanagi, 2007), DC-STAMP, and TRAP
(Zhang et al., 2014) at the binding site with mineralized tissue
(Teitelbaum, 2000), resulting in bone resorption. NFATc-1 is
negatively regulated by IFR-8 (Hu et al., 2010). Furthermore,
osteoclastogenesis can be inhibited by osteoprotegerin which
binds to RANKL, preventing its ligation with RANK in the cell
membrane (Lacey et al., 1998).
After RANK-RANKL interaction, NFATc-1 is expressed in
the cytoplasm within 24 h and its nuclear translocation is more
evident after 48 h, when cell fusion characteristic of osteoclasts
starts, and multi-nucleated TRAP+ cells reach the maximum
expression of TRAP and NFATc-1 after 72 h (Takayanagi et al.,
2002).
Thus, our data evidences that the exposure of osteoclast
precursors to M-CSF and RANKL concomitantly to CDT
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intoxication resulted in initial osteoclastogenesis events,
as shown for increased number of TRAP+ cells, especially
those with 1–2 nuclei. However, the CDT intoxicated cells
were unable to continue differentiating into osteoclasts,
associated with an environmental shift promoted by the
release of inhibitory cytokines and repression of RANK
expression. These events were followed by the inhibition of the
transcription factor nfatc-1, and subsequent inhibition of genes
encoding factors characteristic of mature osteoclasts, such as
cathepsin K.
These observations are in accordance with recent data
showing that CDT causes perturbation of phosphatidylinositol-
3-kinase (PI-3K)/AKT signaling (Shenker et al., 2016), and it is
known that AKT plays a role in osteoclast survival (Lee et al.,
2001) and differentiation (Boyle et al., 2003).
These data may conflict with the bone destruction seen in
aggressive periodontitis. However, imbalanced osteoclastogenesis
is a process resultant from an exacerbated inflammatory process,
with deleterious effects to the infectious agent. Thus, the
inhibition of osteoclastogenesis promoted by AaCDT may
represent its modulatory effect on host immune defenses.
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